Status:
COMPLETED
Dexamethasone for Palliation - Brain Metastases
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Neoplasm Metastasis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Brain metastases occur when cancer cells from the initial tumour site (for example, lung or breast) spread to the brain. This develops in approximately 10% - 30% of adults with cancer. They can produc...
Eligibility Criteria
Inclusion
- Known diagnosis of cancer (even if primary unknown)
- Brain metastases (single or multiple) confirmed by imaging (CT, MRI)
- No contraindication for RT/steroids
- Patient will be treated with Whole Brain Radiation Therapy
- Informed consent
Exclusion
- Primary cancer is lymphoma or leukemia
- Complete surgical excision of brain metastases
- Patient was on steroids for more then 2 weeks prior to entering the study
- Confusion or other factors that would impair ability to assess symptoms
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 28 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00188864
Start Date
November 1 2003
End Date
January 28 2019
Last Update
November 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9